The mainstays of medical therapies for CF CRS include oral and topical antibiotics directed at Pseudomonas aeruginosa and Staphyloccocus aureus species, topical mucolytic agents, and more recently CFTR modulators [6]. The gene discussed is CFTR; the disease is cystic fibrosis.